Managing a patient with presumed testosterone-secreting ovarian tumor

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 175-177

  Lee, Wen Ling ^a   Wang, Peng Hui ^a   Tseng, Hsiuo Shan ^a   Lin, Hong Da ^a   Yuan, Chiou Chung ^a   Chao, Hsiang Tai ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Gonadotropin releasing hormone agonist; Hormone replacement therapy; Testosterone secreting tumor of the ovary

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; CONJUGATED ESTROGEN; ESTRADIOL; GONADORELIN AGONIST; HYDROXYPROGESTERONE; TESTOSTERONE;

AGED; ARTICLE; CASE REPORT; FEMALE; GERIATRIC PATIENT; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OVARY TUMOR; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0032834457     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5507     Document Type: Article

References (19)

1. Barnes R B, Ehrmann D A. Long-term suppression of testosterone after treatment with gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor. J Clin Endocrinol Metab. 82:1997;1746-1748.
2. Kennedy L, Traub A, Atkinson A B. Short term administration of gonadotropin releasing hormone analog to a patient with a testosterone secreting ovarian tumor. J Clin Endocrinol Metab. 64:1987;1320-1322.
3. Steingold K A, Howard L J, Neiberg R K. Treatment of severe androgen excess due to ovarian hyperthecoses with long acting gonadotropin-releasing hormone agonist. Am J Obstet Gynecol. 154:1986;1241-1248.
4. Pascale M M, Pugeat M, Roberts M. Androgen suppressive effect of GnRH agonist in ovarian hyperthecoses and virilizing tumors. Clin Endocrinol. 41:1994;571-576.
5. Martikainen H, Penttinen J, Huhtaniemi I, Kauppila A. Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy. Gynecol Oncol. 35:1989;406-408.
6. Wang P H, Chao H T, Lee W L. Treatment of steroid cell tumors of the ovary by long-acting gonadotrophin releasing hormone agonist. Fertil Steril. 69:1998;353-355.
7. Schencker Y, Malozowski S N, Ayers J. Steroid secretion by a virilizing lipoid cell ovarian tumor: Origin of dehydroepiandrosterone sulfate. Obstet Gynecol. 74:1989;502-506.
8. Doppman J L. Adrenal imaging. Degroot L J. Endocrinology. 1995;1711-1730 Saunders, Philadelphia.
9. Colombo N. Management of sex cord-stromal tumors. Gershenson D M, McGuire W P. Ovarian Cancer. 1998;417-424 Churchill Livingstone, New York.
10. Yin H, Cheng K W, Hwa H L. Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines. Life Sci. 62:1998;2015-2023.
11. Emons G, Ortmann O, Becker M. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res. 53:1993;5439-5446.
12. Takagi H, Imai A, Furui T, Horibe S, Fuseya T, Tamaya T. Evidence for tight coupling kinase in plasma membrane from ovarian carcinomas. Gynecol Oncol. 58:1995;110-115.
13. Palyi I, Vincze B, Kalnay A. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor-positive human cancer cell lines. Cancer Detect Prevent. 20:1996;146-152.
14. Vincze B, Palyi I, Gaal D. In vivo studies of the new gonadotropin-releasing hormone antagonist-copolymer conjugates having antitumor activity. Cancer Detect Prevent. 20:1996;153-159.
15. Ho M N, Delgado C H, Owens G A, Steller M A. Insulin-like growth factor-II participates in the biphasic effect of a gonadotropin-releasing hormone agonist on ovarian cancer cell growth. Fertil Steril. 67:1997;870-876.
16. Imai A, Takagi A, Horibe S. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: Possible mechanism for hormonal control of apoptotic cell death. J Clin Endocrinol Metab. 83:1998;427-431.
17. Imai A, Takagi A, Horibe S. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. J Clin Endocrinol Metab. 81:1996;3249-3253.
18. Imai A, Takagi A, Furui T. Evidence for coupling of phosphotyrosine phospatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane. Cancer. 77:1996;132-137.
19. Lux-Lantos V A, Thyssen S M, Chamson A, Libertun C. Effect of a gonadotropin releasing hormone analog on an experimental ovarian tumor: Direct and indirect actions. Life Sci. 57:1995;291-300.